BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Astellas Pharma Inc
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Leap Therapeutics, Inc.
Trishula Therapeutics, Inc.
Hummingbird Bioscience
IGM Biosciences, Inc.
Taiho Pharmaceutical Co., Ltd.
Seagen Inc.
Case Comprehensive Cancer Center
Cambridge University Hospitals NHS Foundation Trust
H. Lee Moffitt Cancer Center and Research Institute
Theriva Biologics SL
H. Lee Moffitt Cancer Center and Research Institute
Mereo BioPharma
AstraZeneca
Eli Lilly and Company
China Medical University Hospital
Altor BioScience
Barts & The London NHS Trust
Johannes Gutenberg University Mainz
Xiangya Hospital of Central South University
Eli Lilly and Company
University Health Network, Toronto
Incyte Corporation
H. Lee Moffitt Cancer Center and Research Institute
Altor BioScience
Chang Gung Memorial Hospital
University of Kentucky
University of Illinois at Chicago
University of California, San Francisco
Clavis Pharma